Remission induction with lenalidomide alone in a patient with previously untreated plasmablastic myeloma: a case report.

Taimur Sher, Kena C. Miller, Kelvin Lee, Asher Chanan-Khan

Research output: Contribution to journalArticle

9 Scopus citations


Multiple myeloma patients with plasmablastic morphology of tumor cells and extramedullary presentation of disease often have an aggressive clinical course and resistance to chemotherapy. We describe a case of an elderly patient who presented with extramedullary, IgA-lambda-secreting multiple myeloma with plasmablastic features who demonstrated impressive clinical response to single-agent lenalidomide. This is the first description of a plasmablastic variety of multiple myeloma successfully treated with lenalidomide alone.

Original languageEnglish (US)
Pages (from-to)328-330
Number of pages3
JournalClinical lymphoma & myeloma
Issue number4
StatePublished - Aug 2009


ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this